Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

In vivo targeting of activated leukocytes by a β2-integrin binding peptide.

Ranta TM, Suojanen J, Peñate-Medina O, Will O, Tower RJ, Glüer C, Kairemo K, Gahmberg CG, Koivunen E, Sorsa T, Saris PE, Reunanen J.

Mol Diagn Ther. 2014 Feb;18(1):39-44. doi: 10.1007/s40291-013-0052-5.

PMID:
23982749
2.

Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides.

Koivunen E, Ranta TM, Annila A, Taube S, Uppala A, Jokinen M, van Willigen G, Ihanus E, Gahmberg CG.

J Cell Biol. 2001 May 28;153(5):905-16.

3.

Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins.

Stefanidakis M, Bjorklund M, Ihanus E, Gahmberg CG, Koivunen E.

J Biol Chem. 2003 Sep 5;278(36):34674-84. Epub 2003 Jun 24.

4.

Leukocyte arrest during cytokine-dependent inflammation in vivo.

Kunkel EJ, Dunne JL, Ley K.

J Immunol. 2000 Mar 15;164(6):3301-8.

5.

Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion.

Oberyszyn TM, Conti CJ, Ross MS, Oberyszyn AS, Tober KL, Rackoff AI, Robertson FM.

Carcinogenesis. 1998 Mar;19(3):445-55.

PMID:
9525279
6.

Rearrangement of integrins in avidity regulation by leukocytes.

Kucik DF.

Immunol Res. 2002;26(1-3):199-206. Review.

PMID:
12403358
7.

Peptides against Mac-1 do not sufficiently target leukemia or lymphoma in vivo.

Suojanen J, Reunanen J, Ranta TM, Peñate-Medina O, Salo T, Saris P, Sorsa T.

Anticancer Res. 2014 Feb;34(2):645-50.

PMID:
24510994
8.

Shedding of large functionally active CD11/CD18 Integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure.

Gjelstrup LC, Boesen T, Kragstrup TW, Jørgensen A, Klein NJ, Thiel S, Deleuran BW, Vorup-Jensen T.

J Immunol. 2010 Oct 1;185(7):4154-68. doi: 10.4049/jimmunol.1000952. Epub 2010 Sep 8.

9.

Characterization of two novel LPS-binding sites in leukocyte integrin betaA domain.

Wong KF, Luk JM, Cheng RH, Klickstein LB, Fan ST.

FASEB J. 2007 Oct;21(12):3231-9. Epub 2007 May 23.

PMID:
17522381
10.

Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression.

Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10440-5. Epub 2004 Jul 2.

11.

LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion.

Spijkers PP, da Costa Martins P, Westein E, Gahmberg CG, Zwaginga JJ, Lenting PJ.

Blood. 2005 Jan 1;105(1):170-7. Epub 2004 Aug 24.

12.

Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo.

Frommhold D, Mannigel I, Schymeinsky J, Mocsai A, Poeschl J, Walzog B, Sperandio M.

BMC Immunol. 2007 Nov 28;8:31.

13.

Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired β2 integrin function in mice.

Klapproth S, Sperandio M, Pinheiro EM, Prünster M, Soehnlein O, Gertler FB, Fässler R, Moser M.

Blood. 2015 Dec 17;126(25):2704-12. doi: 10.1182/blood-2015-05-647453. Epub 2015 Sep 3.

14.

Leukocyte integrin expression in patients undergoing cardiopulmonary bypass.

Asimakopoulos G, Kohn A, Stefanou DC, Haskard DO, Landis RC, Taylor KM.

Ann Thorac Surg. 2000 Apr;69(4):1192-7.

PMID:
10800818
15.

Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.

Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, Verhoeven AJ, Roos D.

J Clin Invest. 1997 Oct 1;100(7):1725-33.

16.

A novel pathway of rapid TLR-triggered activation of integrin-dependent leukocyte adhesion that requires Rap1 GTPase.

Chung KJ, Mitroulis I, Wiessner JR, Zheng YY, Siegert G, Sperandio M, Chavakis T.

Mol Biol Cell. 2014 Oct 1;25(19):2948-55. doi: 10.1091/mbc.E14-04-0867. Epub 2014 Jul 23.

17.

Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Nolan SL, Kalia N, Nash GB, Kamel D, Heeringa P, Savage CO.

J Am Soc Nephrol. 2008 May;19(5):973-84. doi: 10.1681/ASN.2007111166. Epub 2008 Feb 27.

18.

Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells.

Moser M, Bauer M, Schmid S, Ruppert R, Schmidt S, Sixt M, Wang HV, Sperandio M, Fässler R.

Nat Med. 2009 Mar;15(3):300-5. doi: 10.1038/nm.1921. Epub 2009 Feb 22.

PMID:
19234461
19.

Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activation.

Fan Z, Ley K.

Biorheology. 2015;52(5-6):353-77. doi: 10.3233/BIR-15085. Review.

Supplemental Content

Support Center